‌

US Patent 10300054 Methods for treating antipsychotic-induced weight gain

Patent 10300054 was granted and assigned to Alkermes (company) on May, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Alkermes (company)

0

Current Assignee

Alkermes (company)

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Daniel Deaver0

Mark Todtenkopf0

Date of Patent

May 28, 2019

0

Patent Application Number

159230840

Date Filed

March 16, 2018

0

Patent Citations Received

US Patent 11241425 Composition for treating mental illness

US Patent 11951111 Immediate release multilayer tablet

0

US Patent 11351166 Methods for treating antipsychotic-induced weight gain

US Patent 10822306 Heterocyclic compounds for the treatment of neurological and psychological disorders

US Patent 11707466 Immediate release multilayer tablet

0

Patent Primary Examiner

Shirley V Gembeh

0

Patent abstract

The present invention relates to the discovery of a novel opioid modulator effective in reducing pharmacologically induced weight gain associated with atypical antipsychotic use. The present invention provides methods of reducing antipsychotic induced weight gain, methods for suppressing food intake and reducing ghrelin levels induced by atypical antipsychotic medications in a patient.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10300054 Methods for treating antipsychotic-induced weight gain

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.